Your search returned 3 results.

Results
	1.	Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial. [electronic resource] by Brown, Jennifer R O'Brien, Susan Kingsley, C Daniel Eradat, Herbert Pagel, John M Lymp, James Hirata, Jamie Kipps, Thomas J Producer: 20150803 In: Blood vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLL. [electronic resource] by Brown, Jennifer R O'Brien, Susan Kingsley, C Daniel Eradat, Herbert Pagel, John M Hirata, Jamie McIver, Tammy Morariu-Zamfir, Rodica Kipps, Thomas J Producer: 20191021 In: Blood vol. 133 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer. [electronic resource] by Wakelee, Heather Zvirbule, Zanete De Braud, Filippo Kingsley, C Daniel Mekhail, Tarek Lowe, Thomas Schütte, Wolfgang Lena, Hervé Lawler, William Braiteh, Fadi Cosgriff, Thomas Kaen, Diego Boyer, Michelle Hsu, Jessie Phan, See Novello, Silvia Producer: 20170926 In: Clinical lung cancer vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)